← Back to Search

Bronchodilator

COPD group for Chronic Obstructive Pulmonary Disease (CODEx Trial)

N/A
Waitlist Available
Led By François Maltais, M.D
Research Sponsored by Laval University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline at the end of the exercise.

Summary

This trial is testing new walking and stepping tests for COPD patients to see if slower stepping speeds can better show improvements in breathing after taking medication.

Eligible Conditions
  • Chronic Obstructive Pulmonary Disease
  • Shortness of Breath
  • Heart Failure
  • COPD

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline at 1, 2 and 3 minutes of exercise
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline at 1, 2 and 3 minutes of exercise for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Symptom perception
Secondary study objectives
Cardiac and ventilatory outcomes
Inspiratory capacity
Maximal inspiratory pressure (PImax)
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: COPD groupExperimental Treatment1 Intervention
Moderate and/or severe COPD patients, corresponding to GOLD stages II and III.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Combination ipratropium/salbutamol or placebo (nebulization)
2009
N/A
~60

Find a Location

Who is running the clinical trial?

Laval UniversityLead Sponsor
430 Previous Clinical Trials
178,355 Total Patients Enrolled
Université de MontréalOTHER
221 Previous Clinical Trials
104,240 Total Patients Enrolled
François Maltais, M.DPrincipal InvestigatorInstitut universitaire de cardiologie et de pneumologie de Québec, University Laval
~3 spots leftby Nov 2025